semaglutide shortage update fda On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Novo Nordisk's semaglutide shortage officially

Xiaoyaosan against depression through suppressing LPS mediated TLR4/NLRP3 signaling pathway in microbiota-gut-brain axis

Im doing some work with fiber from corn bran, and individuals consuming relatively high levels (25-30g/day) had greater feelings of satiety and needed less insulin to maintain blood glucose levels

Many drugs have been proposed to treat CVS in the acute phase and on a long term to avoid the recurrences of vomiting crisis

GLP-1 Case Study Name: Richard J., a 58-year-old male Medical History: Type 2 Diabetes Mellitus (diagnosed 7 years ago) Obesity (BMI 35 kg/m) Hypertension (well-controlled on an ACE inhibitor) Mild diabetic retinopathy Current Medications: Metformin 1000 mg twice daily, glimepiride 2 mg once daily, and lisinopril 20 mg once daily Clinical Presentation Richard presents a routine follow-up